Moreover, methylation of the CpG Island II in the CAT promoter, likely driven by the DNMT1 enzyme, is a further crucial element in the regulation of CAT expression in CLL. The gene discussed is DNMT1; the disease is B-cell chronic lymphocytic leukemia.